Fortress Biotech, Inc.
FBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $57 | $81 | $178 | $306 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $10 | $15 | $28 | $24 |
| Inventory | $14 | $10 | $14 | $10 |
| Other Curr. Assets | $8 | $11 | $10 | $7 |
| Total Curr. Assets | $90 | $117 | $230 | $346 |
| Property Plant & Equip (Net) | $17 | $23 | $33 | $34 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $32 | $20 | $27 | $13 |
| Long-Term Investments | $2 | $2 | $3 | $2 |
| Tax Assets | $0 | $0 | -$3 | -$2 |
| Other NC Assets | $3 | $4 | $4 | $3 |
| Total NC Assets | $54 | $51 | $64 | $50 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $144 | $168 | $294 | $397 |
| Liabilities | – | – | – | – |
| Payables | $32 | $35 | $57 | $47 |
| Short-Term Debt | $3 | $9 | $13 | $7 |
| Tax Payable | $1 | $1 | $1 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $3 |
| Other Curr. Liab. | $36 | $40 | $56 | $43 |
| Total Curr. Liab. | $71 | $85 | $128 | $101 |
| LT Debt | $73 | $79 | $115 | $68 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $2 | $2 | $2 |
| Total NC Liab. | $74 | $81 | $117 | $70 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $17 | $18 | $24 | $23 |
| Total Liabilities | $146 | $166 | $244 | $171 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$741 | -$695 | -$634 | -$547 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $764 | $717 | $676 | $656 |
| Total Equity | $23 | $23 | $42 | $109 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$24 | -$21 | $8 | $117 |
| Total Liab. & Tot. Equity | $144 | $168 | $294 | $397 |
| Net Debt | $19 | $8 | -$51 | -$231 |